Q2 2023 Holdings
Filed 2023-08-14 | 20 holdings | $180.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $20.2M | 524,811 | 11.2% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $16.9M | 938,677 | 9.4% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $13.5M | 1,143,368 | 7.5% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $13.3M | 406,225 | 7.3% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $13.0M | 1,187,801 | 7.2% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $12.7M | 1,412,336 | 7.0% |
| Biogen Inc(BIIB) | COM | 09062X103 | $11.7M | 41,047 | 6.5% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $10.2M | 99,495 | 5.7% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $9.8M | 107,406 | 5.4% |
| Morphic Hldg Inc | COM | 61775R105 | $8.7M | 152,360 | 4.8% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $8.4M | 636,158 | 4.7% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $8.0M | 92,626 | 4.5% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $7.0M | 78,442 | 3.9% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $6.7M | 954,856 | 3.7% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $6.2M | 53,995 | 3.4% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $5.3M | 637,857 | 2.9% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $3.6M | 173,717 | 2.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $3.3M | 70,559 | 1.8% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $1.6M | 4,081 | 0.9% |
| Scilex Holding Co(SCLXUSD) | COM | 80880W106 | $57.9K | 10,390 | 0.0% |